Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 3093

Genfit's up to €185M royalty deal; J&J’s Tremfya gets a Crohn's approval

$
0
0
Plus, news about Akeso, Pulmatrix, Autolus, MacroGenics and BlissBio: Genfit completes up to €185M royalty deal: Per the agreement with HealthCare Royalty, the company gets €130 million ($141 million) upfront, with ...

Viewing all articles
Browse latest Browse all 3093

Trending Articles